FDA inspection
Strides Pharma Inc.: FDA inspection ending Feb 16, 2024
FDA inspection 1230104 · No Action Indicated (NAI) · East Brunswick, NJ
Key facts
| Inspection ID | 1230104 |
|---|---|
| Firm | Strides Pharma Inc. |
| FEI number | 3011707936 |
| Address | 2 Tower Center Blvd Ste 1102 |
| City | East Brunswick |
| State | NJ |
| ZIP | 08816 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Feb 16, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data